Brandeau, Margaret L.
Margaret Brandeau American management scientist and engineer
Brandeau, Margaret L. 1955-
VIAF ID: 2717461 (Personal)
Permalink: http://viaf.org/viaf/2717461
Preferred Forms
- 200 _ | ‡a Brandeau ‡b Margaret L.
-
-
-
- 100 1 _ ‡a Brandeau, Margaret L.
-
- 100 1 _ ‡a Brandeau, Margaret L.
-
- 100 1 _ ‡a Brandeau, Margaret L.
- 100 1 _ ‡a Brandeau, Margaret L.
-
-
- 100 1 _ ‡a Brandeau, Margaret L. ‡d 1955-
- 100 0 _ ‡a Margaret Brandeau ‡c American management scientist and engineer
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
- 510 2 _ ‡a Stanford University
Works
Title | Sources |
---|---|
Anticipated burden and mitigation of carbon-dioxide-induced nutritional deficiencies and related diseases: A simulation modeling study | |
Are organic foods safer or healthier? | |
Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? | |
Contact tracing to control infectious disease: when enough is enough | |
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics | |
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States | |
The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men | |
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B | |
Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms | |
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. | |
Creating impact with operations research in health: making room for practice in academia | |
Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice | |
Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions | |
Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases | |
Dynamic treatment selection and modification for personalised blood pressure therapy using a Markov decision process model: a cost-effectiveness analysis. | |
Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics | |
Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters | |
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom | |
Expansion of the National Salt Reduction Initiative: A Mathematical Model of Benefits and Risks of Population-Level Sodium Reduction | |
Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis | |
Hierarchical modeling of seed variety yields and decision making for future planting plans | |
HIV epidemic control-a model for optimal allocation of prevention and treatment resources | |
Improved allocation of HIV prevention resources: using information about prevention program production functions | |
Improving the efficiency of the operating room environment with an optimization and machine learning model | |
Inferring model parameters in network-based disease simulation. | |
A knowledge representation of local pandemic influenza planning models. | |
Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches | |
A little planning goes a long way: multilevel allocation of HIV prevention resources | |
Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections. | |
Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India | |
Modeling complex medical decision problems with the Archimedes model | |
Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic | |
Modeling the AIDS epidemic : planning, policy, and prediction | |
Modeling the logistics of response to anthrax bioterrorism | |
A modified HIV continuum of care: A six-year evaluation of a viral load cascade at a hospital-based clinic in Kingston, Jamaica | |
A national assessment of police command, control, and communications systems, 1983 (a.e.) | |
Operations research and health care a handbook of methods and applications | |
Optimal investment in HIV prevention programs: more is not always better | |
Optimal link removal for epidemic mitigation: a two-way partitioning approach | |
Optimal mix of screening and contact tracing for endemic diseases | |
Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment. | |
Optimizing patient treatment decisions in an era of rapid technological advances: the case of hepatitis C treatment | |
OR Forum—Public Health Preparedness: Answering (Largely Unanswerable) Questions with Operations Research—The 2016–2017 Philip McCord Morse Lecture | |
An ounce of prevention is worth a pound of cure: improving communication to reduce mortality during bioterrorism responses | |
Personalizing Medical Treatment Decisions: Integrating Meta-analytic Treatment Comparisons with Patient-Specific Risks and Preferences | |
Planning the bioterrorism response supply chain: learn and live | |
Predicting and improving patient-level antibiotic adherence | |
Quantifying Positive Health Externalities of Disease Control Interventions: Modeling Chikungunya and Dengue | |
Recommendations for modeling disaster responses in public health and medicine: a position paper of the society for medical decision making | |
Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies | |
Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis | |
Risk stratification in compartmental epidemic models: Where to draw the line? | |
Structural Sensitivity in HIV Modeling: A Case Study of Vaccination | |
Too much of a good thing? When to stop catch-up vaccination | |
Value of quantitative D-dimer assays in identifying pulmonary embolism: implications from a sequential decision model |